Annexon, Inc. — Director's Dealing 2021

Mar 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Annexon, Inc. (ANNX)
CIK: 0001528115
Period of Report: 2021-02-25

Reporting Person: Keswani Sanjay (EVP & Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-25	Stock Option (Right to Buy)	$30.07	A	115000	Acquired	2031-02-25	Common Stock (115000)	Direct

Footnotes

F1: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 25, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.